- As China Slows Down, the Philippines Moves to Grab Foreign Investment
- Why Obamacare Subsidies Should Be Struck Down by the Supreme Court
- MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter
- Shale Oil Bust Enters Phase Two, Led by Hercules and SandRidge
- Comcast Wants Congress to Gut the New Net Neutrality Rules
Jim Cramer and Dan Dicker talk Hercules Offshore, Ensco and SeaDrill.
But Jim Cramer says he likes its yield.
Four holdings are among the U.S. financial institutions being examined.
We would be inclined to trim ABBV if not restricted.
The truth is, we don't know what we want right now.
Jim Cramer explains why he likes everything he's hearing from Target's Brian Cornell.
We discuss why we're bullish on Halyard Health following the company's convincing earnings beat.
The expanded partnership should also provide a decent tailwind for MA's EPS growth.
We need some fear. Then we'll be ready to take out the highs.
We view the report as encouraging and reiterate our $60 price target.